Latest Breaking News On - Deloitte us center - Page 1 : comparemela.com

/PRNewswire/ Key takeaways Projected return on investment in pharma research and development (R&D) in 2023 has risen to 4.1%, climbing back from 2022 s.

United kingdomUnited statesPete lyonsKevin dondarskiDeloitte touche tohmatsuHealth solutionsDeloitte us centerDeloitte united kingdom life sciencesDeloitte consultingDeloitte united kingdom centre for health solutionsHealth carePharmaceutical innovation reportReduction actDeloitte united kingdom centreDeloitte united kingdomLife sciences